Contact by email:
Director (or send email to emeriti@emory.edu) Letters to the Editor Click on the above link to let us know what you think (or send email to emeriti@emory.edu)! |
Upcoming Events
Afternoon Lecture
Nanette Wenger
Monday - 2:00 pm
October 28, 2019
WEBCAST ONLY
Nanette Wenger
Lunch Colloquium
Robert Shapiro
MONDAY
November 4, 2019
WEBCAST ONLY
Robert Shapiro
November 4, 2019
|
|
|
This issue of our newsletter is sent to members and friends of the Emory University Emeritus College (EUEC). I hope the newsletter will help keep you informed about our activities and help you feel connected with our members throughout the U.S. On the left are links to our website and links to contact either me or the EUEC office.
With best wishes, Gray
Gray F. Crouse Director, EUEC
|
Message from the Director
From all accounts, we had another great Lunch Colloquium last week. I really regret that I was out of town and not able to attend, but I did read Lee Pasackow's article, included below. Antibiotic resistance is such an important, and threatening, topic and one that we all need to be aware of. We are so fortunate to have speakers like Maryn McKenna in our Lunch Colloquium series, thanks to Gretchen Schulz and her committee.
I greatly regret that our speaker for next week, Ren Davis, has had to cancel. We hope he will be able to speak to us next semester. We won't have to wait long for another excellent speaker, however. Our own Nanette Wenger will be speaking on the afternoon of October 28. Not only is Nanette a world expert on women's cardiac health, but she is a wonderful speaker and her talk will be important for everyone to hear.
It is also a distinct pleasure to announce the first winner of a Bianchi-Bugge Excellence Award, Oded Borowski. As explained previously, this award now honors both of our co-founders, Eugene Bianchi and John Bugge. The award also helps advance one of our central missions, helping to support members' continuing research activities. You can read about his project below. The winners of this year's Heilbrun Fellowships will be highlighted in the next issue.
I am very grateful to Gretchen Schulz, Ann Hartle, and Marge Crouse for help with editing and proofing.
|
|
|
Afternoon Seminar--Monday, October 28, 2 pm
|
| | Nanette Wenger receiving EUEC Distinguished Faculty Award. |
Understanding the Journey: The Past, Present, and Future of Cardiovascular Disease in Women The Luce Center Room 130 2:00-3:30
Nanette Wenger, MD, MACC, MACP, FAHA, Professor Emerita of Medicine
|
Lunch Colloquium--Tuesday, October 8
Agriculture, Antibiotics, and the Future of Meat
|
Faculty Activities
|
New Members
|
Bianchi-Bugge Excellence Award
As a tribute to both of our co-founders, and with the increased funding due to the contributions of many members in memory of John Bugge, our Bianchi Excellence Awards were renamed the Bianchi-Bugge Excellence Awards. The first award has been made to Oded Borowski, Professor Emeritus of Biblical Archaeology and Hebrew. He provides the following summary of how he will use these funds in support of his research:
After six field seasons of excavations at Tell Halif (Israel), my staff and I accumulated a large amount of culture material that needs to be prepared for final publication. Our site, located about 12 miles northeast of Beersheba, is a mound containing over 23 different layers of occupation going back to the third millennium BCE (Before the Common Era) and up to modern times. Our work concentrated on a layer that contains the remains of a fortified town from the 8th century BCE, which was destroyed by an Assyrian military campaign that is well documented in the Bible and in extra-biblical sources. The campaign, which took place in 701 BCE, was led by the Assyrian King Sennacherib in reaction to a revolt headed by the Judean King Hezekiah.
The houses that were built adjacent to the city wall collapsed as a result of the destructive fires set by the Assyrians and buried under them whatever was kept in them. We recovered large amounts of clay vessels that were smashed on the floors. At this point, we are in the process of reconstructing these vessels to determine what they were used for; this, together with the analysis of installations and implements, will enable us to identify activity areas inside each house and will help illustrate what daily life was like at the moment of destruction.
All antiquities and archaeological discoveries in Israel are the property of the State and remain there. The laws of antiquities in Israel require the analysis of finds and final publication of the results; however, since the data are required to stay in Israel, most of the work needs to be carried out there. Besides, it is very inconvenient and expensive to export pottery for reconstruction and study. The funds provided by the Bianchi-Bugge Award will help in providing transportation and room/board for the staff that comes in the summer from different countries (USA; New Zealand; and Israel) and is kept busy for a month reconstructing the vessels. This process is tedious and lasts for several years.
|
Walking the Campus with Dianne
|
Afternoon Seminar--Monday, October 28, 2 pm - 3:30 pm
Understanding the Journey: The Past, Present, and Future of Cardiovascular Disease in Women
Nanette Wenger, MD, MACC, MACP, FAHA, Professor Emerita of Medicine
This talk will be in 2 parts. The first will be "Understanding the Journey: The Past, Present, and Future of CVD in Women" -- and the second part will be "Show Your Heart You Care®," which presents guidelines for the prevention of cardiovascular disease in women. EUEC Member Nanette Wenger is a world expert in this area. Those of you who have heard her give talks also know that she is a great speaker and that this seminar will be of interest to both men and women. About Nanette Wenger From her biography on the Emory website:
Dr. Wenger is Professor of Medicine in the Division of Cardiology at the Emory University School of Medicine and a consultant to the Emory Heart and Vascular Center.
Coronary heart disease in women is one of Dr. Wenger's major clinical and research interests. She chaired the U.S. National Heart, Lung, and Blood Institute Conference on Cardiovascular Health and Disease in Women. Dr. Wenger has expertise in cardiac rehabilitation. She chaired the World Health Organization Expert Committee on Rehabilitation after Cardiovascular Disease, and co-chaired the Guideline Panel on Cardiac Rehabilitation for the U.S. Agency for Health Care Policy and Research. Dr. Wenger has had a longstanding interest in geriatric cardiology, is a Past President of the Society of Geriatric Cardiology, and was Editor-in-Chief of the American Journal of Geriatric Cardiology for more than 15 years.
Dr. Wenger received the Outstanding Professional Achievement Award from Hunter College (1993) and the Physician of the Year Award of the American Heart Association (1998). In 1999, Dr. Wenger received the Distinguished Achievement Award from the Scientific Councils of the American Heart Association and its Women in Cardiology Mentoring Award. She was chosen by Atlanta Women in Law and Medicine for a Shining Star Award recognizing her distinguished career in cardiology and women's health issues.
In 2000, Dr Wenger was presented the James D. Bruce Memorial Award of the American College of Physicians for distinguished contributions in preventive medicine (2000). In 2002 she received the Distinguished Fellow Award of the Society of Geriatric Cardiology. In 2003, she was included in the National Library of Medicine Exhibition Changing the Face of Medicine: A History of American Women Physicians. Dr. Wenger received the Gold Heart Award, the highest award of the American Heart Association (2004).
At the Emory University 2004 Commencement, Dr. Wenger received the Emory Williams Distinguished Teaching Award of the University and the Evangeline Papageorge Alumni Teaching Award of the Emory University School of Medicine. Dr. Wenger was selected to deliver the 2004 Laennec Lecture of the American Heart Association. In 2006, Dr. Wenger received the Hatter Award, international recognition for the advancement of cardiovascular science. The Georgia Chapter of the American College of Cardiology presented Dr. Wenger its Lifetime Achievement Award in 2009. She was selected Georgia Woman of the Year for 2010. In 2011, Dr. Wenger was selected to deliver the James B. Herrick lecture by the American Heart Association for her outstanding achievement in clinical cardiology. She was elected a member of Emory's 175 Historymakers during Emory's first 175 years.
In 2012, Dr. Wenger received the Charles R. Hatcher, Jr., MD, Award for Excellence in Public Health from Emory University; and was honored in 2013 by the establishment of the J. Willis Hurst, R. Bruce Logue, and Nanette K. Wenger Cardiovascular Society for Emory Cardiology Trainee Alumni. In 2013, she received the Inaugural Distinguished Mentor Award of the American College of Cardiology and the Arnall Patz Lifetime Achievement Award of the Emory University School of Medicine Medical Alumni Association. The American Society of Preventive Cardiology honored Dr. Wenger by naming an annual Nanette K. Wenger Distinguished Lecture focusing on cardiovascular prevention in women (2014).
In 2015, she was awarded the Inaugural Bernadine Healy Leadership in Women's CV Disease Distinguished Award, American College of Cardiology.
Dr. Wenger has participated as an author of several American College of Cardiology/American Heart Association Clinical Practice Guidelines. She is past Chair, Board of Directors, Society for Women's Health Research. Dr. Wenger serves on the editorial boards of numerous professional journals and is a sought-after lecturer for issues related to heart disease in women, heart disease in the elderly, cardiac rehabilitation, coronary prevention, and contemporary cardiac care. She is listed in Best Doctors in America.
Dr. Wenger has authored or coauthored over 1500 scientific and review articles and book chapters.
Even the above information does not list all of her awards, including an EUEC Distinguished Faculty Award for 2017, which you can read about by clicking here.
Click here to return to top
|
Lunch Colloquium--Tuesday, October 8
Agriculture, Antibiotics, and the Future of Meat
Maryn McKenna, Senior Fellow, Center for the Study of Human Health, TED speaker and author of Big Chicken (2017) and Superbug (2010)
At the Lunch Colloquium on Tuesday, October 8, Maryn McKenna, Senior Fellow at Emory College's Center for the Study of Human Health, gave a fascinating yet sobering talk on antibiotics in our food system. As a journalist focusing on public health, she had an obsession that began with her research into the rise of drug resistant bacteria, due in part to the wide use of antibiotics in our meat production. The use of antibiotics in meat production began with chickens; they served as the model for all meat production. Antibiotics were used to make the animals grow quicker and to protect them from diseases that arise in crowded barns. She has discussed that development and its consequences (and attempts to deal with them) in her prize-winning book Big Chicken: The Incredible Story of How Antibiotics Created Modern Agriculture and Changed the Way the World Eats.
McKenna posited that we have arrived at this serious state due to four factors:
- Trusting technology too much;
- Failing to ask questions of science;
- Assuming there is only one path to progress;
- Taking things for granted.
We are losing the power of antibiotics because by misusing and overusing them we have allowed the bacterial world to adapt to them.
Penicillin was the first antibiotic, used widely in WWII. After the war, the food supply was strained and the meat industry was over-extended. To reduce costs, farmers used cheaper feed, which in turn required the use of supplements to provide the needed nutrition. And those supplements began to include small doses of penicillin (and eventually other antibiotics), not to cure infections, as when they're prescribed for people, but to prevent disease and promote growth.
What was most depressing about McKenna's talk was that Alexander Fleming, the scientist who discovered penicillin, warned in his 1945 Nobel Prize speech that using doses of antibiotics that were too small to cure an infection (much less when there was no infection) would allow bacteria to learn to resist the drugs. We didn't listen.
In the U.K. children were developing penicillin allergies, cheese-makers could not make cheese because there was too much penicillin in the milk, there was an outbreak of Salmonella, and 13 children died from a drug-resistant food-borne strain of E. coli. A UK commission in 1969 issued the Swann report, which made the first recommendations for farm antibiotic control.
Slowly the US took note of the UK findings. In the 1970s, Dr. Levy at Tufts University set up an experimental farm. His work proved two things:
- Routine antibiotic doses did affect the gut bacteria of the animals that received them, turning those bacteria toward resistance or increasing the proportion of bacteria that are resistant. When animals were slaughtered, the contents of their guts contaminated the meat they became and traveled on that meat into kitchens and onto plates.
- There was also a risk while farm animals were alive, because their manure would flow into a farm's environment, and the resistant bacteria contained in the manure would begin to move through the world in a manner that was unpredictable.
The FDA tried to take away licenses for growth-promoter uses of antibiotics, but the agricultural lobby prevented this action.
The Scandinavian countries outlawed most farm antibiotic use and the European Union created a total ban on growth promoters in 2006. Sadly, the United States continued to allow growth promoters and waited to see whether resistant bacteria would emerge. They did. And there have been numerous epidemics our usual antibiotics couldn't deal with well.
McKenna hypothesized that we didn't take seriously the threat of antibiotic resistance because we assumed that, however bad resistance might get, there would always be another newer antibiotic to cure it. However, there has been no new antibiotic compound developed in over 30 years; it's just not profitable for Big Pharma.
Predictions are that if we do not change our antibiotic use - in medicine and in protein production - there will be 10M deaths by the year 2050.
Thankfully, McKenna ended her presentation with some positive news. For example, although there is widespread use of antibiotics in fish as well as meat, consumer pressure is forcing some corporations to change their practices in purchasing fish. Costco has cancelled a salmon contract with Chile and is now sourcing from Norway. The cooler waters in the north require less use of antibiotics.
As for chicken, in 2014, Perdue Farms, the fourth-largest chicken producer in the United States, announced that it was taking its chicken antibiotic-free. Other chicken producers quickly followed suit.
In 2016, the central Chinese government banned the antibiotic Colistin from farm use, so we're not getting it from our imports from China anymore.
In January 2017, in one of its final acts, the Obama Administration engineered the removal of growth promoters from the US market, breaking the four-decades stalemate that followed that abortive attempt at regulation so many years ago.
However, these developments are not enough. The US and many countries still allow the preventive use of antibiotics in animals that are not sick. The movement of resistant bacteria across the world shows us that we can no longer pretend one country or ecosystem is separate from another. Foods are flown across the world. Pathogens cross borders on birds, in the wind, in the oceans, and in our bodies. The fight to eliminate the use of antibiotics in our food production continues.
There was a lively Q&A. But time ran out. So in case your Qs weren't answered, you are encouraged to read McKenna's books (like Big Chicken) and articles (published in venues like The York Times Magazine, The New Republic, Smithsonian, The Atlantic, Newsweek, Scientific American, Nature, and The Guardian, among others).
--Lee Pasackow
|
New Members
New members are the lifeblood of any organization. Please make a special effort to welcome them to EUEC!
Carl Holladay, PhD, Charles Howard Candler Professor Emeritus of New Testament
Gray F. Crouse, PhD, Professor Emeritus of Biology I received a BS in Chemistry from Duke University in 1970, a PhD in Chemistry from Harvard University in 1976, was a postdoctoral scholar with Robert Schimke in the Department of Biological Sciences at Stanford University from 1976-1980, and was then a staff scientist at the NCI-Frederick Cancer Research Facility in Frederick, Maryland. I came to Emory as an untenured Associate Professor in Biology in 1984. I mention the dates and degrees because I have found in the past few years that I overlapped at one place or another with various EUEC members, although I don't think we knew each other at the time. When I received the offer of an interview for a faculty position at Emory, I remember asking a colleague whether I should even interview, as my impression of Emory was that of a primarily undergraduate liberal arts college. As it turned out, my colleague had been to Emory to give a seminar in Biology and she assured me that it was a good place and that I should see for myself. I did have a good interview and was impressed by the science at Emory. My concern was whether there was a critical mass of people doing molecular biology at Emory. There were a few such faculty in Biology and some elsewhere, particularly in the Microbiology and Immunology Department, among whom were June Scott, Gordon Churchward, and Charlie Moran. At this point, Emory was at the cusp of a major transformation in the biological and biomedical sciences. Within a decade or so, there would be a major new building for both Biology and the Basic Health Sciences departments, and graduate training would be moved from a departmental structure to the Division of Biological and Biomedical Sciences with substantially increased funding. It has been an incredible opportunity to witness and participate in this transformation. My own research has always strongly benefitted from the collaborative culture of the biological sciences at Emory. When I came to Emory, I was studying various aspects of a gene, dihydrofolate reductase, that was the target of one of the most commonly used chemotherapeutic drugs, methotrexate. For a variety of complex reasons, my research switched to the study of a set of genes involved in DNA mismatch repair, using yeast as a model organism, whose defects in humans lead to colon cancer, and from there my research expanded to study other genes involved in recombination and mutagenesis. One highlight of my research experience was receiving a Fogarty Senior International Fellowship from NIH to study at the Institute of Medical Radiobiology of the University of Zürich, Switzerland, for an entire year. I was also very pleased to be awarded an Emory Williams Distinguished Teaching Award and also to be able to meet Emory Williams at a Board of Trustees meeting. As is also true for many of our members, I have served on a large number of college and university committees including Chair of the Tenure and Promotions Committee and Chair of the Executive Committee of the College, and President of the University Senate and co-chair of the Class and Labor Committee Phase 2: Faculty. Upon my retirement from my faculty position, I was rehired in the Office of the Provost to continue as Director of the Emeritus College for another year. Thanks to the five years I have been Director, I have not had any struggles with the idea of retirement because I have seen so many positive examples of faculty who continue to flourish in retirement. I really appreciate the great role models you are!
|
Faculty Activities
Dana Greene Dean Emerita, Oxford College
Dana Greene, dean emerita of Oxford College, presented two conference papers this summer. One was a keynote given at the Jacopone da Todi Festival in the hill town of Todi, Umbria, Italy and the other a paper on her recent book, Elizabeth Jennings: The Inward War, and the future of biography at Loyola University, Chicago. Greene is now working on a biography of the poet Jane Kenyon.
Many members of the EUEC will remember Dana speaking about Elizabeth Jennings and doing biography at the Sheth Lecture two years ago. Perhaps we will be able to entice her back to speak about Jane Kenyon.
Click here to return to top
|
Walking the Campus with Dianne
Our graffiti covered walls can be found in the Lullwater Tower located near the waterfall area in Lullwater Preserve. Walter Candler, who developed the Lullwater estate in 1925, also built the tower with a generator inside to supply power to his house.
This place is so interesting and maybe a bit spooky, but also peaceful and pretty in a way, with the ever-changing graffiti. Such a wonderful piece of history for the Emory area.
More information can be found in a video created by Gary Hauk, Emory Historian, and new Emeritus College member. Please click here to view.
For our next walk, let's take a look at a place we've been before. The last time we were here, it was a bit dull in appearance...but now it's quite different.
Where will you find this on the Emory Campus?
Click here to return to top
|
Emory University Emeritus College The Luce Center 825 Houston Mill Road NE #206 Atlanta, GA 30329
|
|
|
|
|